BACKGROUND: It has been reported that Asian ethnicity confers a survival benefit in colorectal cancer (CRC) compared with other ethnicities, but it is not known if this is limited to specific Asian subsets. In the current study, the authors attempted to determine differences using data from the large, population-based California Cancer Registry (CCR). METHODS: The authors conducted a case-only analysis of CCR data (1994-2003), including descriptive analysis of relevant clinical variables. Overall survival univariate analyses were conducted using the Kaplan-Meier method. Multivariate survival analyses were performed using Cox proportional hazards ratios (HR). RESULTS: The 61,494 incident cases of colon and 24,350 incident cases of rectal cancer analyzed included 1905 Chinese, 1162 Filipino, 414 Vietnamese, 391 Korean, 1091 Japanese, 148 Asian Indian, and 77,554 Caucasians. After adjustment for age, sex, grade, histology, site within the colon, stage of disease, insurance status, socioeconomic status (SES), and therapy, Filipino (colon: HR, 0.85; 95% confidence interval [95% CI], 0.76-0.95) (rectum: HR, 0.82; 95% CI, 0.71-0.94) and Chinese ethnicity (colon: HR, 0.90; 95% CI, 0.92-0.98) had significantly decreased risk of death compared with Caucasians. Sigmoid lesions were independently associated with improved survival among all cases (HR, 0.92; 95% CI, 0.88-0.95) (referent group were proximal and transverse lesions), and among Asian-only cases in separate analysis (HR, 0.78; 95% CI, 0.70-0.87). CONCLUSIONS: Although survival after CRC diagnosis is improved for Asians in general, significant survival differences are observed only in specific Asian subsets. Data from the current study suggest that survival among Asians is less affected by SES or treatment disparities, and may be because of biologic factors. Copyright (c) 2009 American Cancer Society.
BACKGROUND: It has been reported that Asian ethnicity confers a survival benefit in colorectal cancer (CRC) compared with other ethnicities, but it is not known if this is limited to specific Asian subsets. In the current study, the authors attempted to determine differences using data from the large, population-based California Cancer Registry (CCR). METHODS: The authors conducted a case-only analysis of CCR data (1994-2003), including descriptive analysis of relevant clinical variables. Overall survival univariate analyses were conducted using the Kaplan-Meier method. Multivariate survival analyses were performed using Cox proportional hazards ratios (HR). RESULTS: The 61,494 incident cases of colon and 24,350 incident cases of rectal cancer analyzed included 1905 Chinese, 1162 Filipino, 414 Vietnamese, 391 Korean, 1091 Japanese, 148 Asian Indian, and 77,554 Caucasians. After adjustment for age, sex, grade, histology, site within the colon, stage of disease, insurance status, socioeconomic status (SES), and therapy, Filipino (colon: HR, 0.85; 95% confidence interval [95% CI], 0.76-0.95) (rectum: HR, 0.82; 95% CI, 0.71-0.94) and Chinese ethnicity (colon: HR, 0.90; 95% CI, 0.92-0.98) had significantly decreased risk of death compared with Caucasians. Sigmoid lesions were independently associated with improved survival among all cases (HR, 0.92; 95% CI, 0.88-0.95) (referent group were proximal and transverse lesions), and among Asian-only cases in separate analysis (HR, 0.78; 95% CI, 0.70-0.87). CONCLUSIONS: Although survival after CRC diagnosis is improved for Asians in general, significant survival differences are observed only in specific Asian subsets. Data from the current study suggest that survival among Asians is less affected by SES or treatment disparities, and may be because of biologic factors. Copyright (c) 2009 American Cancer Society.
Authors: Jason A Zell; Jessica M Rhee; Argyrios Ziogas; Steven M Lipkin; Hoda Anton-Culver Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-03 Impact factor: 4.254
Authors: Jeffrey A Meyerhardt; Edward L Giovannucci; Michelle D Holmes; Andrew T Chan; Jennifer A Chan; Graham A Colditz; Charles S Fuchs Journal: J Clin Oncol Date: 2006-07-05 Impact factor: 44.544
Authors: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charles S Fuchs Journal: J Clin Oncol Date: 2006-07-05 Impact factor: 44.544
Authors: Melissa McCracken; Miho Olsen; Moon S Chen; Ahmedin Jemal; Michael Thun; Vilma Cokkinides; Dennis Deapen; Elizabeth Ward Journal: CA Cancer J Clin Date: 2007 Jul-Aug Impact factor: 508.702
Authors: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Frank B Hu; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James Thomas; Charles S Fuchs Journal: JAMA Date: 2007-08-15 Impact factor: 56.272
Authors: Wendy Lee; Rebecca Nelson; Brian Mailey; Marjun Philip Duldulao; Julio Garcia-Aguilar; Joseph Kim Journal: J Gastrointest Surg Date: 2012-01-19 Impact factor: 3.452
Authors: Jen Chun Kuan; Chang Chieh Wu; Chien An Sun; Chi Ming Chu; Fu Gong Lin; Chih Hsiung Hsu; Po-Chieh Kan; Shih-Chieh Lin; Tsan Yang; Yu-Ching Chou Journal: PLoS One Date: 2015-03-27 Impact factor: 3.240
Authors: Loraine Kay D Cabral; Cynthia A Mapua; Filipinas F Natividad; Caecilia H C Sukowati; Edgardo R Cortez; Ma Luisa D Enriquez Journal: World J Gastrointest Oncol Date: 2021-12-15
Authors: M Yi; J Xu; P Liu; G J Chang; X L Du; C-Y Hu; Y Song; J He; Y Ren; Y Wei; J Yang; K K Hunt; X Li Journal: Br J Cancer Date: 2013-03-07 Impact factor: 7.640